China Biotech Services Holdings Limited
Символ: 8037.HK
HKSE
0.305
HKDПазарна цена днес
-2.1085
Съотношение P/E
0.0000
Коефициент PEG
293.79M
MRK Cap
- 0.04%
Доходност на DIV
China Biotech Services Holdings Limited (8037-HK) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 790.46 | 206.9 | 92.8 | 152.3 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 558.67 | 0 | -128.6 | 1.8 | ||||||||||||||||||
balance-sheet.row.net-receivables | 135.51 | 39.2 | 768.5 | 117.6 | ||||||||||||||||||
balance-sheet.row.inventory | 28.39 | 9.3 | 18.7 | 4.7 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 14.98 | 5.8 | 4.8 | 3.1 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 969.35 | 261.2 | 884.8 | 277.8 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 234.55 | 124.2 | 128.9 | 105.5 | ||||||||||||||||||
balance-sheet.row.goodwill | 212.74 | 107.2 | 110.1 | 120.6 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 130.78 | 69.8 | 67.3 | 80.9 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 343.52 | 177 | 177.4 | 201.5 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 264.64 | 56.9 | 227.7 | 120.3 | ||||||||||||||||||
balance-sheet.row.tax-assets | -150.08 | 57.6 | -227.7 | 0 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | -95.53 | -14.6 | 279.5 | 1.8 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 597.1 | 401.2 | 585.7 | 429 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 1566.44 | 662.4 | 1470.5 | 706.8 | ||||||||||||||||||
balance-sheet.row.account-payables | 17.61 | 5.8 | 206.4 | 16.1 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 103.28 | 94.7 | 16.6 | 63.6 | ||||||||||||||||||
balance-sheet.row.tax-payables | 117.69 | 3.7 | 242 | 85.2 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 66.02 | 5.7 | 65.2 | 3.6 | ||||||||||||||||||
Deferred Revenue Non Current | -5.73 | -5.7 | 0 | -9.9 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 13.38 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 209.83 | 58.6 | 325.2 | 23.7 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 86.8 | 12.2 | 95.3 | 13.5 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 19.7 | 5.7 | 20.3 | 11.1 | ||||||||||||||||||
balance-sheet.row.total-liab | 418.86 | 171.6 | 644 | 240.9 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 192.65 | 96.3 | 96.3 | 96.3 | ||||||||||||||||||
balance-sheet.row.retained-earnings | -560.83 | -310.8 | -209.9 | -475.1 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1540.97 | 186.5 | 225.6 | 283.5 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1317.72 | 490.7 | 490.7 | 490.7 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 2490.51 | 462.8 | 602.7 | 395.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3049.83 | 662.4 | 1470.5 | 706.8 | ||||||||||||||||||
balance-sheet.row.minority-interest | 140.46 | 28 | 223.8 | 70.5 | ||||||||||||||||||
balance-sheet.row.total-equity | 2630.97 | 490.7 | 826.5 | 465.9 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3049.83 | - | - | - | ||||||||||||||||||
Total Investments | 823.31 | 56.9 | 99.2 | 122 | ||||||||||||||||||
balance-sheet.row.total-debt | 169.3 | 100.4 | 81.8 | 67.2 | ||||||||||||||||||
balance-sheet.row.net-debt | 55.18 | -106.5 | -11 | -83.4 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -146.31 | -95.4 | 862.8 | 180.7 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 55.58 | 55.6 | 66.4 | 68.1 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 381.7 | 0 | 7.8 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 2.42 | 1.9 | 2 | 5.2 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 494.8 | -433.3 | -225.5 | ||||||||||||||||||
cash-flows.row.account-receivables | 0 | 729.9 | -656.4 | -64.9 | ||||||||||||||||||
cash-flows.row.inventory | 0 | -2.2 | -14 | -2.4 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | -232.9 | 237.1 | -158.3 | ||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | 394.46 | -645.9 | -15.2 | 4.2 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 192.57 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -62.9 | -69.8 | -12.2 | ||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 7.5 | -6.5 | 0.5 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -51.8 | -0.5 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0.1 | 4.1 | ||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -128.4 | 0 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -55.41 | -55.4 | -256.3 | -8.1 | ||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -31.1 | -8.2 | -52.2 | ||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3.6 | -3 | -4.3 | ||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -9.6 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -156 | -270.8 | -210.1 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -149.41 | -149.4 | -282 | -266.6 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 126.38 | -2.2 | -2.3 | 0.2 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 114.13 | 114.1 | -57.8 | -234 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 452.29 | 206.9 | 92.8 | 150.6 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 338.17 | 92.8 | 150.6 | 384.5 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 192.57 | 192.6 | 482.7 | 40.5 | ||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -62.9 | -69.8 | -12.2 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 192.57 | 129.7 | 413 | 28.3 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 230.34 | 212 | 1851.5 | 623.8 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 207.42 | 177.7 | 750.6 | 265.7 | ||||||||||||||||||
income-statement-row.row.gross-profit | 22.92 | 34.3 | 1101 | 358 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 29.04 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 138.34 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 14.61 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0.48 | 0.6 | -3.4 | 0.7 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 192.26 | 158 | 251.5 | 168.8 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 399.68 | 335.7 | 1002.1 | 434.5 | ||||||||||||||||||
income-statement-row.row.interest-income | 3.74 | 3.7 | 0.2 | 0 | ||||||||||||||||||
income-statement-row.row.interest-expense | 5.31 | 5.3 | 3.5 | 6.5 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 14.61 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -9.25 | -10.7 | 11.1 | -8.8 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.48 | 0.6 | -3.4 | 0.7 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | -9.25 | -10.7 | 11.1 | -8.8 | ||||||||||||||||||
income-statement-row.row.interest-expense | 5.31 | 5.3 | 3.5 | 6.5 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 13.77 | 55.6 | 58.4 | 68.1 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | -169.51 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | -183.28 | -123.7 | 851.7 | 189.4 | ||||||||||||||||||
income-statement-row.row.income-before-tax | -192.53 | -134.3 | 862.8 | 180.7 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | -1.75 | -1.3 | 157.3 | 48.1 | ||||||||||||||||||
income-statement-row.row.net-income | -123.34 | -95.4 | 705.6 | 132.6 |
Често задавани въпроси
Какво е China Biotech Services Holdings Limited (8037.HK) общи активи?
China Biotech Services Holdings Limited (8037.HK) общите активи са 662362000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 47983000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.200.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.200.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.535.
Какъв е общият приход на предприятието?
Общият приход е -0.796.
Каква е China Biotech Services Holdings Limited (8037.HK) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -95447000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 100396000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 158009000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 206896000.000.